BioTelemetry, Inc. Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
BioTelemetry (BEAT) Tops Q1 EPS by 2c; Withdraws Guidance
May 6, 2020 4:29 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $113 million versus the consensus estimate of $113.11 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
I would like to first express my sincere gratitude to the entire BioTelemetry team and to our many customers, suppliers and partners for their unwavering commitment... More
